Not Signed In - Barr Receives Tentative Approval For Generic KYTRIL(R) Tablets, 1mg (Base)
Sat, 20 Jan 2007 08:00 AM EST
... Barr Pharmaceuticals, Inc. (NYSE: BRL) today announced that its subsidiary, Barr Laboratories, Inc. has received tentative approval from the U.S. Food and Drug Administration (FDA) for its generic version of Roche Laboratories Inc.'s KYTRIL(R) (granisetron hydrochloride) Tablets, 1mg (base). [click link for full article] ...
Related Topics
- Epstein Barr Virus
- Granisetron
- Carbinoxamine and Pseudoephedrine Tablets
- Finasteride
- Glimepiride
- Vaccine Testing & Approval
- Carbinoxamine and Pseudoephedrine Extended-Release Tablets
- Cyanocobalamin Tablets
- Frequent infections especially with Epstein-Barr virus
- Epstein-Barr Virus (EBV) Infection
- Chlorpheniramine, Pseudoephedrine and Hydrocodone Tablets
- Guaifenesin and Dextromethorphan
- Neostigmine Tablets
- Haloperidol Tablets
- Thiabendazole Tablets
- Granisetron Hydrochloride Injection
- Anastrozole
- Carbetapentane, Phenylephrine, and Pyrilamine
- National Data
- Ergoloid Mesylates Sublingual Tablets
email this page
print this page
bookmark this page
feedback on this page
